由ATOX1驱动的ECM降解和血管光滑肌细胞亡加速了大动脉剖析进展
Yuling Xie1, Xinfan Lin1, Xu Han2
1Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China; Fujian Provincial Center for Cardiovascular Medicine, Fuzhou, Fujian, China.
Biochimica et biophysica acta. Molecular basis of disease
|December 18, 2025
概括
抗氧化剂-1 (ATOX1) 蛋白在大动脉剖析 (AD) 中升高. 抑制ATOX1减少了细胞外基质降解和细胞亡,为AD提供了潜在的新治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 生物化学 生化学
背景情况:
- 大动脉剖析 (AD) 涉及细胞外基质 (ECM) 降解和血管光滑肌细胞 (VSMC) 亡.
- 抗氧化剂-1 (ATOX1) 在AD病变发生中的作用,特别是ECM降解和VSMC亡,需要进一步研究.
研究的目的:
- 阐明ATOX1在阿尔茨海默病发展中的作用.
- 研究ATOX1作为阿尔茨海默病的潜在治疗点.
主要方法:
- 高通量测序确定了AD患者ATOX1表达的增加.
- 使用组织染色,RT-PCR和西部斑点的验证证实了AD模型和细胞中ATOX1的升高.
- 在体外研究涉及人类大动脉血管光滑肌细胞 (HAVSMCs) 中的ATOX1沉默和药理抑制 (DC_AC50).
- 在体内研究中,在a-aminopropionitrile (BAPN) 诱导的小鼠模型中,利用腺相关病毒载体9 (AAV9) 进行向性淘汰和药理学抑制.
- 研究了miR-133b和ATOX1.1.之间的监管关系.
主要成果:
- 在AD患者,小鼠模型和 ангиотензинII诱导的HAVSMC中,ATOX1的表达显著增加.
- 沉默或抑制ATOX1降低了HAVSMC中的铜离子水平,矩阵金属蛋白酶 (MMP) 分泌和亡.
- 在小鼠模型中,针对性地降低或药理上抑制ATOX1减缓了AD的进展.
- miR-133b,在AD下调,与ATOX1相反相关,可以逆转ATOX1诱导的影响.
- 在小鼠中,miR-133b的过度表达减弱了AD的进展.
结论:
- 抑制ATOX1可能会减轻ECM降解和VSMC亡,从而减缓AD的进展.
- 抑制ATOX1是一种有前途的治疗策略,用于大动脉解剖.
相关概念视频
Atherosclerosis I: Introduction
795
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
795
Coronary Artery Disease II: Pathophysiology
340
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
340


